MeiraGTx Receives UK Regulatory Clearances for Hologen Transaction
MeiraGTx secures UK regulatory approvals for Hologen acquisition, advancing gene therapy pipeline. #MeiraGTx #GeneTherapy
Topic
Finance
Finance news
Conduent Appoints Harsha V. Agadi as Board Chairman and Scott Letier to Lead Audit Committee
Conduent names Harsha V. Agadi as board chairman and Scott Letier as audit committee chair, strengthening governance. #Conduent #CorporateGovernance
China Automotive Systems Announces Merger Agreement for Redomicile to Cayman Islands
China Automotive Systems announces merger to redomicile to Cayman Islands, aiming to enhance corporate structure and shareholder value. #ChinaAutomotiveSystems #Redomicile
Hyster-Yale Secures $300 Million Revolving Credit Facility Maturing in 2030
Hyster-Yale secures $300M revolving credit facility to support growth and liquidity through 2030. #HysterYale #CreditFacility
Grayscale Digital Large Cap Fund Plans Name Change and NYSE Arca Listing
Grayscale Digital Large Cap Fund announces plans for a name change and listing on NYSE Arca to enhance market presence. #Grayscale #DigitalAssets
Curbline Properties Announces $150 Million Private Placement of Senior Notes
Curbline Properties secures $150M via private placement of senior notes to support growth and refinancing. #CurblineProperties #PrivatePlacement
T1 Energy Shareholders Approve Board Slate and Auditor at Annual Meeting
T1 Energy shareholders approve board members and auditor, reinforcing governance and financial oversight. #T1Energy #CorporateGovernance
Maia Biotechnology Enters Stock Purchase Agreement for Up to $587,905 with Prevail Partners
Maia Biotechnology secures up to $587,905 through stock purchase agreement with Prevail Partners, supporting its growth and R&D efforts. #MaiaBiotechnology #StockPurchase
Monday.com Schedules Annual General Meeting for July 31 in Tel Aviv
Monday.com announces annual general meeting on July 31 in Tel Aviv, focusing on governance and strategic initiatives. #MondayDotCom #AGM2025
Cellectar Biosciences Enacts One-for-Thirty Reverse Stock Split on Nasdaq
Cellectar Biosciences completes one-for-thirty reverse stock split on Nasdaq to enhance share price and meet listing requirements. #CellectarBiosciences #ReverseStockSplit